Abingdon Health PLC - York, England-based lateral flow contract research and contract development & manufacturing organisation - Aims to raise up to £500,000 from a retail offer of shares at 9.75 pence each, the same price at while it raised £5.2 million from a share placing with institutional investors. The retail offer opens on Monday and closes on Wednesday next week. The equity raise comes as Abingdon completes its acquisition of CS Lifesciences group, which trades as Compliance Solutions and offers consultancy on meeting medical regulatory compliance requirements. Abingdon issues 9.2 million initial consideration shares for the acquisition.

Current stock price: 9.96p

12-month change: down 9.5%

Copyright 2024 Alliance News Ltd. All Rights Reserved.